2025-04-17 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Report

**0. Executive Summary:**

Intuitive Surgical Inc. (ISRG) is a leading medical device company specializing in robotic-assisted surgery.  Based on the provided data, ISRG exhibits strong historical performance, significantly outperforming the S&P 500 (VOO) over various periods, although recent performance has lagged.  While current indicators show some weakness, long-term growth potential remains.


**1. Performance Comparison with S&P 500:**

* **ISRG Cumulative Return:** 108.61%
* **VOO (S&P 500) Cumulative Return:** 76.10%
* **Return Difference:** 32.51%
* **Relative Deviation:** 36.9% (This indicates ISRG's outperformance is in the upper 37th percentile of its historical range relative to the S&P 500.)

**Alpha and Beta Analysis:**

The provided data shows variable alpha and beta values across different periods.  While generally exhibiting a beta higher than 1 (indicating higher volatility than the market), it also shows periods of strong alpha (outperformance relative to the market), particularly between 2017 and 2021. The recent negative CAGR suggests a market correction. Market capitalization increased significantly over the time periods.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 68.0% | 56.5% | 35.0% | -0.0 | 43.6 |
| 2016-2018  | 77.0% | 63.4% | 56.0% | -0.1 | 57.2 |
| 2017-2019  | 81.0% | 63.4% | 47.0% | 0.4 | 70.6 |
| 2018-2020  | 47.0% | 63.4% | 17.0% | 0.4 | 97.7 |
| 2019-2021  | 91.0% | 63.0% | 31.0% | 0.4 | 128.7 |
| 2020-2022  | -3.0% | 69.9% | -12.0% | 0.5 | 95.1 |
| 2021-2023  | -5.0% | 72.9% | -26.0% | 1.1 | 120.9 |
| 2022-2024  | 26.0% | 72.9% | 5.0% | 1.1 | 187.0 |
| 2023-2025  | 29.0% | 72.9% | 15.0% | 0.7 | 172.4 |


**2. Recent Price Action:**

* **Closing Price:** $481.34
* **Previous Close:** $488.27
* **Change:** -$1.42 (a slight decrease)
* **5-Day Moving Average:** $488.57
* **20-Day Moving Average:** $492.67
* **60-Day Moving Average:** $539.22

The price is below all three moving averages, suggesting a short-term bearish trend.

**3. Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.41 (Medium Risk)
* **RSI:** 43.96 (Approaching oversold territory, but not yet definitively so)
* **PPO:** 0.44 (Positive, indicating bullish momentum, but weakening)
* **20-Day Relative Strength Change:** -7.8% (Short-term bearish)
* **Expected Return (vs. S&P 500):** 47.9% (Long-term projected outperformance over two years or more.)

The price decrease of $1.42 is not significant enough to be labeled a "sharp drop."

**4. Recent Earnings Analysis:**

| Date       | EPS  | Revenue     |
|------------|------|-------------|
| 2024-10-18 | $1.59 | $2.04B      |
| 2024-07-19 | $1.48 | $2.01B      |
| 2024-04-19 | $1.54 | $1.89B      |
| 2023-10-20 | $1.18 | $1.74B      |
| 2024-10-18 | $1.18 | $1.74B      | *(Duplicate entry, likely a data error)*

Revenue has remained relatively stable, with slight increases. EPS shows some fluctuation but generally positive growth.  The duplicate entry needs clarification.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue    | Profit Margin |
|---------|-------------|---------------|
| 2024-12-31 | $2.41B     | 68.04%        |
| 2024-09-30 | $2.04B     | 67.41%        |
| 2024-06-30 | $2.01B     | 68.30%        |
| 2024-03-31 | $1.89B     | 65.87%        |
| 2023-12-31 | $1.93B     | 66.24%        |

Revenue is showing a clear upward trend. Profit margins are consistently high, though there is some minor quarter-to-quarter fluctuation.

**Capital and Profitability:**

| Quarter | Equity (B) | ROE (%) |
|---------|-------------|---------|
| 2024-12-31 | $16.43     | 4.17    |
| 2024-09-30 | $15.58     | 3.63    |
| 2024-06-30 | $14.71     | 3.58    |
| 2024-03-31 | $13.96     | 3.90    |
| 2023-12-31 | $13.31     | 4.56    |

Equity is steadily increasing, indicating strong financial health. ROE shows some variability but remains generally positive.


**6. Overall Analysis:**

ISRG has demonstrated significant historical outperformance compared to the S&P 500.  However, recent price action and CAGR suggest a period of consolidation or correction.  While technical indicators show some bearish signals (price below moving averages, slightly negative recent relative strength change, RSI nearing oversold), the strong long-term growth projections and consistent profitability remain positive factors.  The company's financial health appears sound, with growing revenue and equity.  Further investigation into the duplicate earnings data point and the reasons behind recent underperformance is recommended before making any investment decisions.  The high projected long-term expected return relative to the S&P 500 suggests that for long-term investors, ISRG may still be a worthwhile consideration despite the recent market correction.
